MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Benzodiazepine toxicity

Important safety information

Flumazenil should only be administered by, or under the direct supervision of, personnel experienced in its use

NG225: Self-harm: assessment, management and preventing recurrence, September 2022

Flumazenil is a benzodiazepine antagonist for the reversal of the central sedative effects of benzodiazepines after anaesthetic and similar procedures. Flumazenil has a shorter half-life and duration of action than diazepam or midazolam so patients may become resedated